<p>Rare disease drug developers face three major market access challenges in the EU market today. Parexel Pricing and Market Access expert, Sangeeta Budhia, shares what they need to know to succeed.</p>

Rare disease drug developers face three major market access challenges in the EU market today. Parexel Pricing and Market Access expert, Sangeeta Budhia, shares what they need to know to succeed.

Three trends impacting market access in the EU

This podcast focuses on topics relating to the global journey to create a healthier world through developing innovative new therapies for patients everywhere.

Share Three trends impacting market access in the EU

Sign up to save your podcasts

Three trends impacting market access in the EU

Three trends impacting market access in the EU